Panel Discussion: Outlining Current Industry Trends in Oligonucleotide Development

Time: 9:10 am
day: Day 1


  • Discussing the movement away from the development of oligonucleotides for rare diseases
  • Capitalizing on opportunities and changes we anticipate in the future and newer complex oligos coming into pipelines
  • Outlining challenges of scale, impurity characterization and qualification